- Home
- PMT vs BBOT Comparison
PMT vs BBOT Comparison
Compare PMT & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMT | BBOT |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMT | BBOT |
|---|---|---|
| Price | $12.24 | $11.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $13.67 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 1.5M | 346.9K |
| Earning Date | 01-29-2026 | 02-26-2026 |
| Dividend Yield | ★ 13.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | ★ $721,170,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.66 | N/A |
| P/E Ratio | $12.23 | ★ N/A |
| Revenue Growth | ★ 42.92 | N/A |
| 52 Week Low | $11.60 | $8.50 |
| 52 Week High | $14.93 | $14.87 |
Technical Indicators
Market Signals| Indicator | PMT | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 40.15 | 44.53 |
| Support Level | $11.70 | $11.63 |
| Resistance Level | $13.64 | $12.55 |
| Average True Range (ATR) | 0.41 | 0.77 |
| MACD | -0.17 | -0.05 |
| Stochastic Oscillator | 28.27 | 19.94 |
Price Performance
Historical ComparisonAbout PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.